David Siegel, MD, Hematologist/Oncologist, Hackensack University Medical Center, John Theurer Cancer Center, discusses TOURMALINE-MM3 Study And The Treatment Of MM.…
Browsing: Multiple Myeloma
Maria-Victoria Mateos, MD, Associate Professor of Medicine, University of Salamanca, discusses TOURMALINE-MM3 Study. At The 60th ASH Annual Meeting on…
Ravi Vij, MD, Professor of Medicine, Oncology Division, Bone Marrow Transplantation & Leukemia, Washington University School of Medicine, discusses Anti-BCMA…
Maria-Victoria Mateos, MD, Associate Professor of Medicine, University of Salamanca, discusses Outcomes From The ALCYONE Study. At The 60th ASH…
David Siegel, MD, Hematologist/Oncologist, Hackensack University Medical Center, John Theurer Cancer Center, discusses Anti-BCMA CAR-T Cell Therapy For MM Patients.…
Rafael Fonseca, MD Hematologist, Mayo Clinic, discusses Effectiveness Of Anti-BCMA CAR-T Cell Therapy. At The 60th ASH Annual Meeting on…
Rafael Fonseca, MD Hematologist, Mayo Clinic, discusses Outcomes Of The POLLUX And CASTOR Studies. At The 60th ASH Annual Meeting…
Sundar Jagannath, MD Professor of Medicine, Hematology and Medical Oncology, Mount Sinai School of Medicine, discusses Outcomes Of CA204-142 In…
Peter Vorhees, MD Director of Outreach and Clinical Operations, Department of Hematologic Oncology and Blood Diosrders, Levine Cancer Institute, discusses…
Nizar Bahlis, MD University of Calgary, Calgary, discusses The Future Of Anti-BCMA CAR-T Cell Therapy In MM. At The 60th…
Katja Weisel, MD Head of the Myeloma Center, University of Tubingen, discusses Current Maintenance Regimens In MM. At The 60th…
Maria-Victoria Mateos, MD Associate Professor of Medicine, University of Salamanca, discusses Addition Of Daratumumab To Revlimid/Dexamethasone In MM. At The…
Sen Zhuang, MD, PhD VP, Oncology Clinical Research, Janssen, discusses How LCAR-838M May Impact The Treatment Of MM. At The…
Edward Copelan, MD Chair, Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, discusses The Role Of Allogeneic Transplantation…
Andrzej Jakubowiak, MD Professor of Medicine Director, Myeloma Program University of Chicago Medical Center, discusses GRIFFIN Study Outcomes. At The…
Habte Yimer, MD Hematologist/Oncologist, US Oncology Research Executive Council Member, Texas Oncology, discusses Discussing The POLLUX And CASTOR Studies. At…
Habte Yimer, MD Hematologist/Oncologist, US Oncology Research Executive Council Member, Texas Oncology, discusses The Future Of Anti-BCMA CAR-T Cell Therapy.…
Habte Yimer, MD Hematologist/Oncologist, US Oncology Research Executive Council Member, Texas Oncology, discusses Outcomes Of The GRIFFIN Study. At The…
Maria-Victoria Mateos, MD Associate Professor of Medicine, University of Salamanca, discusses Discussing The CASTOR Trial Presented At ASH 2018. At…
Sundar Jagannath, MD Professor of Medicine, Hematology and Medical Oncology, Mount Sinai School of Medicine, discusses Maintenance Regimens For Multiple…
Robert Rifkin, MD Hematologist/Oncologist, Associate Chair, US Oncology Hematology Research, Rocky Mountain Cancer Centers Discusses Does Anti-BCMA CAR-T Cell Therapy…
Andrew Pecora, MD Chief Innovation Officer, Professor and Vice President of Cancer Services John Theurer Cancer Center Discusses The Necessity…
David Siegel, MD Hematologist/Oncologist, Hackensack University Medical Center, John Theurer Cancer Center Discusses Results Of MM014 Study. At The 60th…
Andrzej Jakubowiak, MD, PhD Professor of Medicine Director, Myeloma Program, University of Chicago Medical Center discusses Multiple Myeloma Maintenance Regimens.…
Nikhil Munshi, MD Director of Basic and Correlative Science, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Professor of Medicine,…
Rafael Fonseca, MD Hematologist, Mayo Clinic Discusses Maintenance Regimens For MM At The 60th ASH Annual Meeting on Dec 1,…
Peter Vorhees, MD Director of Outreach and Clinical Operations, Department of Hematologic Oncology and Blood Diosrders, Levine Cancer Institute Discusses…
Habte Yimer, MD, Hematologist/Oncologist, US Oncology Research Executive Council Member, Texas Oncology Discusses Lyra Trial In Newly Diagnosed MM At…
Sen Zhuang, MD, PhD, VP, Oncology Clinical Research, Janssen, Discusses LCAR-838M Study In Relapsed/Refractory MM At The 60th ASH Annual…
Rod A. Humerickhouse, M.D., PhD Group Project Leader, Oncology Development, AbbVie Discusses Venetoclax In Treatment Of MM At The 60th…
Nizar Bahlis, M.D. University of Calgary, Calgary Discusses ASH 2018: CASTOR & POLLUX Studies Impact At The 60th ASH Annual…
Adriana Rossi, M.D. Associate Clinical Director Myeloma Center Weill Cornell Medicine Discusses Whats On The Horizon For Myeloma at Lymphoma…
Adriana Rossi, M.D. Associate Clinical Director Myeloma Center Weill Cornell Medicine Discusses Triplet Drug Combo at Lymphoma & Myeloma on…
Adriana Rossi, M.D. Associate Clinical Director Myeloma Center Weill Cornell Medicine Discusses The Role Of Ixazomib In Front Line Therapy…
Adriana Rossi, M.D. Associate Clinical Director Myeloma Center Weill Cornell Medicine Discusses Renal Insufficiency At Time Of Diagnosis at Lymphoma…
Adriana Rossi, M.D. Associate Clinical Director Myeloma Center Weill Cornell Medicine Discusses MRD Not Ready Outside Clinicial Trials at Lymphoma…
Adriana Rossi, M.D. Associate Clinical Director Myeloma Center Weill Cornell Medicine Discusses Front Line Therapy Of Myeloma at Lymphoma &…
Joseph Mikhael, M.D. Professor in the Applied Cancer Research and Drug Discovery Division at the Translational Genomics Research Institute (TGen)…
Joseph Mikhael, M.D. Professor in the Applied Cancer Research and Drug Discovery Division at the Translational Genomics Research Institute (TGen)…
Joseph Mikhael, M.D. Professor in the Applied Cancer Research and Drug Discovery Division at the Translational Genomics Research Institute (TGen)…
C. Ola Landgren, M.D. Chief of the Myeloma Service in the Division of Hematologic Oncology at Memorial Sloan Kettering Cancer…
C. Ola Landgren, M.D. Chief of the Myeloma Service in the Division of Hematologic Oncology at Memorial Sloan Kettering Cancer…
C. Ola Landgren, M.D. Chief of the Myeloma Service in the Division of Hematologic Oncology at Memorial Sloan Kettering Cancer…
C. Ola Landgren, M.D. Chief of the Myeloma Service in the Division of Hematologic Oncology at Memorial Sloan Kettering Cancer…
C. Ola Landgren, M.D. Chief of the Myeloma Service in the Division of Hematologic Oncology at Memorial Sloan Kettering Cancer…
Samir Parekh, M.D. Associate Professor of medicine, hematology, medical oncology, and oncological sciences at the Icahn School of Medicine at…
Suzanne Lentzsch, M.D., PhD Associate Professor of Medicine & Director of the Multiple Myeloma and Amyloidosis Service at Columbia University…
Shaji Kumar, M.D. Professor of Medicine Mayo Clinic College of Medicine In Rochester, Minnesota Discusses Allogeneic Stem Cell Transplant: Multiple…
Habte Yimer, M.D. Chairman, Hematology/Oncology Department, CHRISTUS Trinity Mother Frances Hospital, Medical Oncology Specialist in Tyler, TX Discusses Where Does…
Habte Yimer, M.D. Chairman, Hematology/Oncology Department, CHRISTUS Trinity Mother Frances Hospital, Medical Oncology Specialist in Tyler, TX Discusses Lyra: Front…